Antibody-drug conjugates for non-oncological indications.
about
Human Serum Albumin Domain I Fusion Protein for Antibody Conjugation.Trends in therapeutic drug conjugates for bacterial diseases: a patent review.Strategies and challenges for the next generation of antibody-drug conjugates.Novel linkers and connections for antibody-drug conjugates to treat cancer and infectious disease.An anti-EGFR × cotinine bispecific antibody complexed with cotinine-conjugated duocarmycin inhibits growth of EGFR-positive cancer cells with KRAS mutations.
P2860
Antibody-drug conjugates for non-oncological indications.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Antibody-drug conjugates for non-oncological indications.
@en
Antibody-drug conjugates for non-oncological indications.
@nl
type
label
Antibody-drug conjugates for non-oncological indications.
@en
Antibody-drug conjugates for non-oncological indications.
@nl
prefLabel
Antibody-drug conjugates for non-oncological indications.
@en
Antibody-drug conjugates for non-oncological indications.
@nl
P2860
P1476
Antibody-drug conjugates for non-oncological indications.
@en
P2093
P2860
P304
P356
10.1517/14712598.2016.1161753
P407
P577
2016-03-03T00:00:00Z